We Ran for Fun Through Hyde Park!

Posted:
7
June 2004

7th June 2004We Ran for Fun Through Hyde Park!

[Runners in Hyde park]

Four Richmond Pharmacology managers braved the recent 10k Capital FM Bupa Featbeat fun run through Hyde Park! Sarah Willison, Victoria Blades, Chris Robinson and Sian Dale took part in the fund raising event, held on 23 May 2004.Our runners joined 7,000 other fun runners to raise money for Help a London Child. The run started at the Prince of Wales Gate in Hyde Park, taking runners along New Ride and up to Hyde Park Corner. Runners then ran past Grosvenor Gate and around the The Ring to The Serpentine lake. At which point, runners had to turnaround and run all the way back again!Victoria, Head of Clinical Project Management, commented “I felt fine until we reached The Serpentine but then my heart sank when I realized we had to run all the way back again! I think I need to take the training a bit more seriously before the next fun run!”Sarah Willison, Senior Project Manager, added “The last two miles didn’t feel fun! It was a great atmosphere though – the crowd were fantastic.”Richmond Pharmacology sponsored the four runners, donating £600 to the charity. They have already agreed to run the Windsor Half Marathon on 26 September 2004.Victoria commented: “Running over twice as far as we did in Hyde Park will certainly be a challenge! But its good to contribute in some small way to Help a London Child, so I had better get some training mileage done in the meantime!”For more information on events to raise funds for Help a London Child please visit www.capitalfm.com

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more